Unmet needs and emerging therapeutics in low-grade serous ovarian carcinoma: from chemoresistance to precision medicine.
Saved in:
| Title: | Unmet needs and emerging therapeutics in low-grade serous ovarian carcinoma: from chemoresistance to precision medicine. |
|---|---|
| Authors: | Slomovitz BM; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA., Podder V; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA., Crane E; Division of Gynecologic Oncology, Levine Cancer Institute at Atrium Health, Wake Forest University, Charlotte, NC, USA., Brown J; Division Director of Gynecologic Oncology, Levine Cancer Institute at Atrium Health, Wake Forest University, Charlotte, NC, USA. |
| Source: | Future oncology (London, England) [Future Oncol] 2025 Dec; Vol. 21 (29), pp. 3833-3843. Date of Electronic Publication: 2025 Nov 05. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
